These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25581117)

  • 21. [Risk-benefit analysis for mass screening of breast cancer utilizing mammography as a screening test].
    Iinuma TA; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Sep; 49(9):1091-5. PubMed ID: 2587191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for breast cancer after the age of 70: effect on breast cancer mortality].
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):428-33. PubMed ID: 7891764
    [No Abstract]   [Full Text] [Related]  

  • 24. United States Preventive Services Task Force screening mammography recommendations: science ignored.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening has not reduced deaths from breast cancer, study shows.
    Wise J
    BMJ; 2013 Jun; 346():f3780. PubMed ID: 23757734
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of screening mammography in the era of modern breast cancer treatment.
    Miller AB
    Climacteric; 2018 Jun; 21(3):204-208. PubMed ID: 29338480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of mammography for older women.
    Finucane TE
    Ann Intern Med; 2004 May; 140(10):844; author reply 844. PubMed ID: 15148077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 31. Supporting statements and rationale.
    Costanza ME; Annas GJ; Brown ML; Cassel CK; Champion V; Cohen HJ; Frame PS; Glasse L; Mor V; Pauker SG
    J Gerontol; 1992 Nov; 47 Spec No():7-16. PubMed ID: 1430887
    [No Abstract]   [Full Text] [Related]  

  • 32. Age and interval for screening mammography: whom do you believe?
    Venta LA; Goodhartz LA
    Semin Surg Oncol; 1996; 12(5):281-9. PubMed ID: 8873315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast care imaging: ghost of past?
    Emahiser LJ; Wood BD
    Radiol Technol; 2012; 83(4):397-400. PubMed ID: 22461349
    [No Abstract]   [Full Text] [Related]  

  • 34. Older women, mammography, and mortality from breast cancer.
    Nattinger AB
    Am J Med; 2000 Feb; 108(2):174-5. PubMed ID: 11126313
    [No Abstract]   [Full Text] [Related]  

  • 35. Lessons from the Swiss Medical Board recommendation against mammography screening programs.
    Chiolero A; Rodondi N
    JAMA Intern Med; 2014 Oct; 174(10):1541-2. PubMed ID: 25154463
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Brenner H; Heywang-Köbrunner S; Becker N
    J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365
    [No Abstract]   [Full Text] [Related]  

  • 37. Retrospective cost-effectiveness analysis of screening mammography.
    Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
    J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In the clinic. Breast cancer screening and prevention.
    Nattinger AB
    Ann Intern Med; 2010 Apr; 152(7):ITC41. PubMed ID: 20368645
    [No Abstract]   [Full Text] [Related]  

  • 39. The elusive goal of maintaining population cancer screening: it is time for a new paradigm.
    Mandelblatt J; Buist D
    J Natl Cancer Inst; 2010 Jul; 102(14):998-9. PubMed ID: 20587793
    [No Abstract]   [Full Text] [Related]  

  • 40. Breast Cancer Risk Assessment Models and High-Risk Screening.
    Barke LD; Freivogel ME
    Radiol Clin North Am; 2017 May; 55(3):457-474. PubMed ID: 28411673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.